# Influence of Age on the Choice of Treatment and Prognosis in Patients With Resectable Gastric Cancer

> **NCT07403916** · — · ACTIVE_NOT_RECRUITING · sponsor: **P. Herzen Moscow Oncology Research Institute** · enrollment: 90 (actual)

## Conditions studied

- Gastric Cancer (GC)
- Next-generation Sequencing
- Molecular Analysis

## Interventions

- **DIAGNOSTIC_TEST:** Next-generation sequencing

## Key facts

- **NCT ID:** NCT07403916
- **Lead sponsor:** P. Herzen Moscow Oncology Research Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-01-10
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07403916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07403916, "Influence of Age on the Choice of Treatment and Prognosis in Patients With Resectable Gastric Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07403916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*